Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5244
Gene Symbol: ABCB4
ABCB4 		0.330 AlteredExpression disease BEFREE Using this method we determined the MDR3 mRNA levels in 52 liver specimens from primary biliary cirrhosis (n=11), chronic hepatitis B (n=5), chronic hepatitis C (n=14), non-cholestatic cirrhosis (n=9) and controls (n=13). 9126799 1997
Entrez Id: 3627
Gene Symbol: CXCL10
CXCL10 		0.310 Biomarker disease CTD_human Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. 18422935 2008
Entrez Id: 4283
Gene Symbol: CXCL9
CXCL9 		0.310 Biomarker disease CTD_human Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. 18422935 2008
Entrez Id: 3627
Gene Symbol: CXCL10
CXCL10 		0.310 AlteredExpression disease LHGDN Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives. 16243485 2005
Entrez Id: 4283
Gene Symbol: CXCL9
CXCL9 		0.310 AlteredExpression disease LHGDN Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives. 16243485 2005
Entrez Id: 954
Gene Symbol: ENTPD2
ENTPD2 		0.310 Biomarker disease CTD_human Ectonucleotidase NTPDase2 is selectively down-regulated in biliary cirrhosis. 15651265 2004
Entrez Id: 954
Gene Symbol: ENTPD2
ENTPD2 		0.310 AlteredExpression disease LHGDN Ectonucleotidase NTPDase2 is selectively down-regulated in biliary cirrhosis. 15651265 2004
Entrez Id: 1432
Gene Symbol: MAPK14
MAPK14 		0.300 Biomarker disease CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 213
Gene Symbol: ALB
ALB 		0.300 Biomarker disease CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 114757
Gene Symbol: CYGB
CYGB 		0.300 Biomarker disease CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 4846
Gene Symbol: NOS3
NOS3 		0.300 Biomarker disease CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 9817
Gene Symbol: KEAP1
KEAP1 		0.300 Biomarker disease CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 4780
Gene Symbol: NFE2L2
NFE2L2 		0.300 Biomarker disease CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 5970
Gene Symbol: RELA
RELA 		0.300 Biomarker disease CTD_human Hepatoprotective effects of diosmin and/or sildenafil against cholestatic liver cirrhosis: The role of Keap-1/Nrf-2 and P38-MAPK/NF-κB/iNOS signaling pathway. 30026087 2018
Entrez Id: 3594
Gene Symbol: IL12RB1
IL12RB1 		0.300 SusceptibilityMutation disease RGD Increased IL-23 and IL-17 expression by peripheral blood cells of patients with primary biliary cirrhosis. 23910013 2013
Entrez Id: 7297
Gene Symbol: TYK2
TYK2 		0.300 Biomarker disease CTD_human Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. 22961000 2012
Entrez Id: 3091
Gene Symbol: HIF1A
HIF1A 		0.300 Biomarker disease CTD_human Hypoxia-inducible factor activation in myeloid cells contributes to the development of liver fibrosis in cholestatic mice. 22271822 2012
Entrez Id: 643
Gene Symbol: CXCR5
CXCR5 		0.300 Biomarker disease CTD_human Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. 21399635 2011
Entrez Id: 163486
Gene Symbol: DENND1B
DENND1B 		0.300 Biomarker disease CTD_human Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. 21399635 2011
Entrez Id: 941
Gene Symbol: CD80
CD80 		0.300 Biomarker disease CTD_human Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. 21399635 2011
Entrez Id: 3575
Gene Symbol: IL7R
IL7R 		0.300 Biomarker disease CTD_human Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. 21399635 2011
Entrez Id: 4790
Gene Symbol: NFKB1
NFKB1 		0.300 Biomarker disease CTD_human Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. 21399635 2011
Entrez Id: 3855
Gene Symbol: KRT7
KRT7 		0.300 Biomarker disease CTD_human Expression of cytokeratin 7 as a histological marker of cholestasis and stages of primary biliary cirrhosis. 21681009 2011
Entrez Id: 3593
Gene Symbol: IL12B
IL12B 		0.300 Biomarker disease CTD_human Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. 20639880 2010
Entrez Id: 3385
Gene Symbol: ICAM3
ICAM3 		0.300 Biomarker disease CTD_human Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. 18422935 2008